Health-related quality of life outcomes from KEYNOTE-412: chemoradiotherapy with or without pembrolizumab in participants with head and neck squamous cell carcinoma
KEYNOTE-412研究中与健康相关的生活质量结果:接受或不接受帕博利珠单抗治疗的头颈部鳞状细胞癌患者的放化疗
期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1645509
Machiels, J-P; Tao, Y; Licitra, L; Burtness, B; Tahara, M; Rischin, D; Alves, G V; Lima, I P F; Hughes, B G M; Pointreau, Y; Aksoy, S; Laban, S; Greil, R; Burian, M; Hetnal, M; Delord, J-P; Mesia, R; Taberna, M; Waldron, J; Simon, C; Gregoire, V; Harrington, K; Black, C M; Norquist, J M; Wang, A; Gumuscu, B; Bidadi, B; Siu, L L